lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

Clinical Characteristics and Health Care Cost Among Patients Successfully Treated for COVID-19 in Henan, China: A Descriptive Study

19 Pages Posted: 2 Jun 2020

See all articles by Yudong Miao

Yudong Miao

Independent

Soumitra S Bhuyan

Independent

Yi Kang

Independent

Jianqin Gu

Zhengzhou University

Sabiha Hussain

Independent

Jian Wu

Independent

Jia Shang

Independent

Xiaojv Zhang

Independent

Meiyun Wang

Zhengzhou University - Department of Radiology; Key Lab in Imaging Diagnosis and Research of Central Nervous System Diseases

Liuyi Wang

Independent

Min Liu

Independent

Ruirui Cheng

Zhengzhou University

Urmi Basu

Independent

Zhanjun Chang

Independent

Mengzhu Liu

Independent

Feng Liu

Independent

Huayu Zhang

Independent

More...

Abstract

Background: COVID-19 epidemic has become a significant public health crisis affecting global health. We aimed further to clarify the clinical and medical expense characteristics of COVID-19.

Methods: In this retrospective, single-center study, we included all cured cases with confirmed COVID-19 in Henan Provincial People's Hospital from Jan 23 to Mar 10, 2020. Cases were analyzed for demographic, epidemiological, clinical, and radiological features and medical expense data. 

Findings: The average age of the 54 successfully treated patients with COVID-19 was 53.2 years old (SD 19.0), including 27 men and 27 women. Off this, 31 (57.4%) patients had chronic diseases. Patients commonly had clinical manifestations of fever (45 [83.3%] patients), cough (29[54.7%] patients), expectoration (28 [51.9%] patients), fatigue (24[44.4%] patients) and diarrhea (8[14.8%] patients) on admission. There was a 10-day interval from the onset of signs and symptoms to hospital admission. About 80% of them got recovery after a two-week treatment. During the treatment, 43(78.2%) patients had at least one comorbid illness, and 11(20.4%) had more than five comorbid illnesses. The mean interval from the onset of signs and symptoms to hospital discharge was 20.5 (IQR 16-29) days. The median total medical expense of the treated patient, in general, was 2579.6 (IQR 1366.1-4837.6) U.S. dollars. Still, the median medical expense was 8904.1 (IQR 6660.1- 27143.8) U.S. dollars in patients with more than five comorbid conditions during the treatment.

Interpretation: There is a 3-week interval from the onset of signs and symptoms to cure, and most hospitalized patients get recovery within two weeks. Although COVID-19 can result in fatal respiratory diseases and even death. The total medical expense of cases with more than five comorbid conditions during the treatment is higher. Quite a few COVID cases with other serious diseases are likely to account for most of the total medical expenses.

Funding Statement: This study was funded by National Natural Science Foundation of China (number 71603132), and the Central Government Guides the Development of Local Science and Technology Special Fund of China (number Z135050009017).

Declaration of Interests: The authors declare no competing interests.

Ethics Approval Statement: The study was approved by the Henan Provincial People's Hospital Ethics Committee

Keywords: COVID-19; Clinical characteristics; Health care cost

Suggested Citation

Miao, Yudong and Bhuyan, Soumitra S and Kang, Yi and Gu, Jianqin and Hussain, Sabiha and Wu, Jian and Shang, Jia and Zhang, Xiaojv and Wang, Meiyun and Wang, Liuyi and Liu, Min and Cheng, Ruirui and Basu, Urmi and Chang, Zhanjun and Liu, Mengzhu and Liu, Feng and Zhang, Huayu, Clinical Characteristics and Health Care Cost Among Patients Successfully Treated for COVID-19 in Henan, China: A Descriptive Study (4/24/2020). Available at SSRN: https://ssrn.com/abstract=3588531 or http://dx.doi.org/10.2139/ssrn.3588531

Yudong Miao

Independent

Soumitra S Bhuyan

Independent

Yi Kang

Independent

Jianqin Gu (Contact Author)

Zhengzhou University ( email )

100 Science Avenue
Zhengzhou, Henan 450001
China

Sabiha Hussain

Independent

Jian Wu

Independent

Jia Shang

Independent

Xiaojv Zhang

Independent

Meiyun Wang

Zhengzhou University - Department of Radiology ( email )

7 Weiwu Road
Zhengzhou, Henan 450003
China

Key Lab in Imaging Diagnosis and Research of Central Nervous System Diseases ( email )

Zhengzhou, Henan
China

Liuyi Wang

Independent

Min Liu

Independent

Ruirui Cheng

Zhengzhou University

100 Science Avenue
Zhengzhou, Henan 450001
China

Urmi Basu

Independent

Zhanjun Chang

Independent

Mengzhu Liu

Independent

Feng Liu

Independent

Huayu Zhang

Independent

Click here to go to TheLancet.com

Paper statistics

Abstract Views
876
Downloads
26
PlumX Metrics